CTOs on the Move

CareData Patient Tracking Systems Corporation

www.caredata.biz

 
CareData Patient Tracking Systems Corporation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.caredata.biz
  • 70 W Madison St Ste 1400
    Chicago, IL USA 60602
  • Phone: 312.214.3155

Executives

Name Title Contact Details

Similar Companies

Cleveland Rape Crisis Center

Supporting survivors of sexual abuse and rape, promoting healing and prevention, and advocating for social change in Northeast Ohio

LifeTek Solutions

LifeTek Solutions is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VersaPharm Incorporated

VersaPharm Incorporated is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

TrialAssure

TrialAssure – the technology arm of MMS Holdings – is an award-winning, global clinical trial disclosure and transparency reporting suite with unmatched experience in helping clients navigate complex regulatory submission and reporting challenges. TrialAssure helps meet regulatory compliance goals through a flexible, scalable, and streamlined platform that regularly adapts to ever-changing clinical trial disclosure requirements. Established in 2009, the TrialAssure suite was built from the ground up as a single, integrated transparency system, and it is continually strengthened by the experience of leading pharmaceutical industry compliance experts.

Norbrook

Norbrook® is a true innovator and dedicated to novel research and revolutionary processes and products. Lord Ballyedmond, Founder, Chairman and CEO of the Norbrook Group began his career in the pharmaceutical industry in the USA in the 1960s and now controls the largest privately owned pharmaceutical company in the world.    The company is very active in both medical and veterinary products.    Research and Development is the key to Norbrook`s success with the R&D Department central to the company`s structure. It is responsible for new product development, technical support and meeting regulatory and licensing protocols. Norbrook invests more than 10% of its turnover annually in research and development of new products.    The company is at the forefront of formulation technology and has developed many new chemical routes for the synthesis of active materials. Norbrook has formulated and registered more than 800 products in 120 countries.    The on-going success of the company is conditional on the expertise, knowledge and innovation of the staff employed. Norbrook prides itself on attracting the highest calibre of individual to the company and boasts a multi-national workforce committed to constantly pushing the boundaries and challenging technologies to ensure that Norbrook remains the leading force in pharmaceuticals that it is today.